◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

BioSyent Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 12.2M 10.2M 11.0M 8.8M 9.6M --
Operating Revenue 12.2M 10.2M 11.0M 8.8M 9.6M --
Cost Of Revenue 3.0M 2.3M 2.6M 1.6M 2.1M --
Gross Profit 9.3M 7.9M 8.3M 7.2M 7.5M --
Selling General And Administration 5.2M 5.0M 5.0M 4.3M 4.6M --
General And Administrative Expense 3.0M 3.0M 3.2M 2.5M 2.8M --
Research And Development 127,500 47,944 89,380 55,209 64,395 --
Depreciation And Amortization In Income Statement 202,205 212,641 211,183 236,320 116,843 --
Other Operating Expenses 357,329 48,301 54,789 55,850 83,152 --
Operating Expense 5.9M 5.3M 5.4M 4.8M 4.8M --
Operating Income 3.4M 2.6M 2.9M 2.4M 2.7M --
EBIT 3.7M 2.8M 3.2M 2.3M 3.0M --
Interest Expense 12,141 12,631 13,103 13,971 14,579 --
Interest Expense Non Operating 12,141 12,631 13,103 13,971 14,579 --
Interest Income 231,389 210,934 179,010 260,088 256,890 --
Interest Income Non Operating 231,389 210,934 179,010 260,088 256,890 --
Net Interest Income 219,248 198,303 165,907 246,117 242,311 --
Other Income Expense 21,499 -19,089 41,868 -354,979 71,550 --
Gain On Sale Of Security 21,499 -19,089 41,868 75,037 71,550 --
Pretax Income 3.6M 2.7M 3.2M 2.3M 3.0M --
Tax Provision 967,102 727,640 836,438 637,715 667,210 --
Tax Effect Of Unusual Items 5,697 -5,059 11,095 -100,571 16,046 --
Net Income From Continuing And Discontinued Operation 2.7M 2.0M 2.3M 1.6M 2.3M --
Net Income From Continuing Operation Net Minority Interest 2.7M 2.0M 2.3M 1.6M 2.3M --
Net Income Including Noncontrolling Interests 2.7M 2.0M 2.3M 1.6M 2.3M --
Net Income Common Stockholders 2.7M 2.0M 2.3M 1.6M 2.3M --
Net Income 2.7M 2.0M 2.3M 1.6M 2.3M --
EBITDA 3.9M 3.0M 3.4M 2.5M 3.1M --
Normalized EBITDA 3.8M 3.0M 3.3M 2.9M 3.0M --
Reconciled Depreciation 202,205 212,641 211,183 236,320 116,843 --
Basic EPS 0.24 0.18 0.21 -- 0.20 0.14
Diluted EPS 0.23 0.18 0.20 -- 0.20 0.13
Basic Average Shares 11.3M 11.3M 11.3M -- 11.6M 11.6M
Diluted Average Shares 11.5M 11.5M 11.5M -- 11.8M 11.8M
Total Unusual Items 21,499 -19,089 41,868 -354,979 71,550 --
Total Unusual Items Excluding Goodwill 21,499 -19,089 41,868 -354,979 71,550 --
Tax Rate For Calcs 0.27 0.27 0.27 0.28 0.22 --
Normalized Income 2.7M 2.0M 2.3M 1.9M 2.3M --
Amortization 135,852 144,566 144,276 164,207 46,545 --
Amortization Of Intangibles Income Statement 135,852 144,566 144,276 164,207 46,545 --
Depreciation Amortization Depletion Income Statement 202,205 212,641 211,183 236,320 116,843 --
Depreciation Income Statement 66,353 68,075 66,907 72,113 70,298 --
Diluted NI Availto Com Stockholders 2.7M 2.0M 2.3M 1.6M 2.3M --
Insurance And Claims 43,824 54,148 62,770 49,673 49,674 --
Net Income Continuous Operations 2.7M 2.0M 2.3M 1.6M 2.3M --
Net Non Operating Interest Income Expense 219,248 198,303 165,907 246,117 242,311 --
Other Gand A 520,129 461,665 566,405 567,852 405,498 --
Provision For Doubtful Accounts -- -- -- 136,491 0.00 0.00
Reconciled Cost Of Revenue 3.0M 2.3M 2.6M 1.6M 2.1M --
Salaries And Wages 2.5M 2.4M 2.6M 1.8M 2.3M --
Selling And Marketing Expense 2.1M 2.1M 1.8M 1.9M 1.8M --
Total Expenses 8.8M 7.6M 8.0M 6.4M 6.9M --
Total Operating Income As Reported 3.4M 2.5M 3.0M 2.0M 2.7M --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 16.6M 13.9M 11.0M 12.1M 12.8M --
Cash Cash Equivalents And Short Term Investments 23.4M 20.4M 17.4M 15.9M 17.1M --
Cash Equivalents 2.5M 3.5M 2.5M 2.5M 2.5M --
Cash Financial 14.0M 10.4M 8.4M 9.6M 10.3M --
Other Short Term Investments 6.8M 6.4M 6.4M 3.8M 4.3M --
Accounts Receivable 5.5M 4.2M 4.5M 2.4M 3.9M --
Receivables 6.3M 4.9M 5.5M 3.0M 4.4M --
Inventory 5.9M 4.9M 5.3M 5.3M 5.7M --
Prepaid Assets 339,938 443,573 484,654 201,971 391,940 --
Current Assets 36.0M 30.6M 28.6M 24.5M 27.6M --
Gross PPE 3.4M 3.4M 3.4M 3.4M 3.3M --
Accumulated Depreciation -2.4M -2.3M -2.2M -2.2M -2.1M --
Net PPE 1.0M 1.1M 1.2M 1.2M 1.3M --
Goodwill And Other Intangible Assets 4.9M 4.8M 5.0M 5.0M 5.7M --
Other Intangible Assets 4.9M 4.8M 5.0M 5.0M 5.7M --
Investments And Advances 5.4M 6.5M 7.5M 10.1M 10.5M --
Total Non Current Assets 11.8M 12.9M 14.1M 16.9M 17.9M --
Total Assets 47.8M 43.5M 42.8M 41.4M 45.5M --
Current Debt And Capital Lease Obligation 211,575 207,081 201,806 196,627 191,497 --
Accounts Payable 6.4M 3.8M 4.8M 4.0M 6.3M --
Payables 6.7M 4.0M 5.5M 4.4M 6.5M --
Payables And Accrued Expenses 6.7M 4.0M 5.5M 4.4M 6.5M --
Current Deferred Revenue 161,504 824,103 123,316 813,198 342,206 --
Other Current Liabilities 16,460 12,921 8,660 -- -- --
Current Liabilities 7.1M 5.0M 5.8M 5.4M 7.0M --
Long Term Debt And Capital Lease Obligation 681,303 735,151 788,412 841,104 892,879 --
Long Term Capital Lease Obligation 681,303 735,151 788,412 841,104 892,879 --
Total Non Current Liabilities Net Minority Interest 775,772 852,372 903,733 951,159 1.1M --
Total Liabilities Net Minority Interest 7.9M 5.9M 6.8M 6.4M 8.1M --
Common Stock 5.2M 5.2M 5.1M 5.3M 5.1M --
Capital Stock 5.2M 5.2M 5.1M 5.3M 5.1M --
Additional Paid In Capital 2.0M 1.9M 1.8M 2.1M 2.2M --
Retained Earnings 32.8M 30.7M 29.3M 27.7M 30.3M --
Gains Losses Not Affecting Retained Earnings -172,212 -179,191 -172,225 -171,554 -202,798 --
Common Stock Equity 39.9M 37.6M 36.0M 35.0M 37.3M --
Stockholders Equity 39.9M 37.6M 36.0M 35.0M 37.3M --
Total Equity Gross Minority Interest 39.9M 37.6M 36.0M 35.0M 37.3M --
Total Capitalization 39.9M 37.6M 36.0M 35.0M 37.3M --
Net Tangible Assets 35.0M 32.8M 31.0M 30.0M 31.6M --
Tangible Book Value 35.0M 32.8M 31.0M 30.0M 31.6M --
Working Capital 28.9M 25.6M 22.8M 19.1M 20.5M --
Invested Capital 39.9M 37.6M 36.0M 35.0M 37.3M --
Total Debt 892,878 942,232 990,218 1.0M 1.1M --
Share Issued 11.5M 11.5M 11.5M 11.5M 11.8M --
Ordinary Shares Number 11.3M 11.3M 11.3M 11.3M 11.6M --
Accrued Interest Receivable 689,793 583,796 589,666 477,709 419,125 --
Buildings And Improvements 1.3M 1.3M 1.3M 1.3M 1.3M --
Capital Lease Obligations 892,878 942,232 990,218 1.0M 1.1M --
Current Capital Lease Obligation 211,575 207,081 201,806 196,627 191,497 --
Current Deferred Liabilities 161,504 824,103 123,316 813,198 342,206 --
Finished Goods 3.9M 4.0M 4.0M 4.3M 4.9M --
Foreign Currency Translation Adjustments -172,212 -179,191 -172,225 -171,554 -202,798 --
Hedging Assets Current 0.00 0.00 0.00 5,790 22,252 --
Held To Maturity Securities 5.4M 6.5M 7.5M 10.1M 10.5M --
Income Tax Payable 310,462 192,598 756,560 396,343 249,332 --
Investmentin Financial Assets 5.4M 6.5M 7.5M 10.1M 10.5M --
Leases 680,511 680,511 680,511 680,511 680,511 --
Loans Receivable 57,240 56,098 52,004 87,433 68,917 --
Machinery Furniture Equipment 1.1M 1.1M 1.1M 1.1M 662,783 --
Non Current Deferred Assets 342,359 371,104 380,206 401,166 301,224 --
Non Current Deferred Liabilities 94,469 117,221 115,321 110,055 197,328 --
Non Current Deferred Taxes Assets 342,359 371,104 380,206 401,166 301,224 --
Non Current Deferred Taxes Liabilities 94,469 117,221 115,321 110,055 197,328 --
Non Current Note Receivables 84,003 84,093 123,170 141,140 156,926 --
Other Properties 277,339 276,104 266,367 266,367 673,742 --
Other Receivables 53,943 35,855 354,900 34,191 33,350 --
Properties 0.00 0.00 0.00 0.00 0.00 --
Raw Materials 2.0M 866,675 1.2M 981,253 745,589 --
Total Tax Payable 310,462 192,598 756,560 396,343 249,332 --
Treasury Shares Number 213,165 214,629 216,483 207,199 203,294 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow 2.8M 3.5M -718,398 2.6M 6.6M --
Cash Flow From Continuing Operating Activities 2.8M 3.5M -718,398 2.6M 6.6M --
Depreciation And Amortization 202,205 212,641 211,183 236,320 116,843 --
Depreciation Amortization Depletion 202,205 212,641 211,183 236,320 116,843 --
Stock Based Compensation 158,344 157,703 149,736 151,620 140,405 --
Deferred Tax 5,993 11,002 26,226 -187,213 24,179 --
Deferred Income Tax 5,993 11,002 26,226 -187,213 24,179 --
Change In Working Capital -63,130 1.3M -3.3M 470,185 4.3M --
Change In Receivables -1.2M 1.6M -3.5M 1.6M 1.3M --
Change In Inventory -1.0M 416,629 50,844 331,507 369,968 --
Change In Payables And Accrued Expense 2.8M -1.5M 1.1M -2.0M 1.8M --
Change In Payable -- -1.5M 1.1M -- -- 626,081
Change In Other Working Capital -748,479 700,785 -689,881 332,774 286,019 --
Other Non Cash Items -220,301 -199,891 -167,933 -249,469 -244,530 --
Capital Expenditure -240,319 -43,769 -88,357 -- -4.6M -117,319
Purchase Of PPE -1,692 -18,729 -19,900 -18,395 -12,537 --
Net PPE Purchase And Sale -1,692 -18,729 -19,900 -18,395 -12,537 --
Purchase Of Investment -- -- -2.6M 393,142 -2.1M -4.3M
Sale Of Investment -- -- 2.6M 455,827 1.3M 11.0M
Net Investment Purchase And Sale 684,963 1.0M -13,801 848,969 -771,159 --
Investing Cash Flow 450,869 171,694 1.1M 882,824 -5.0M --
Cash Flow From Continuing Investing Activities 450,869 171,694 1.1M 882,824 -5.0M --
Repayment Of Debt -49,354 -47,986 -47,513 -46,645 -46,038 --
Net Issuance Payments Of Debt -49,354 -47,986 -47,513 -46,645 -46,038 --
Repurchase Of Capital Stock -327,173 0.00 -668,780 -3.2M -302,450 --
Net Common Stock Issuance -327,173 0.00 -668,780 -3.2M -302,450 --
Common Stock Dividend Paid -- -- -563,311 -512,891 -- --
Common Stock Payments -327,173 0.00 -668,780 -3.2M -302,450 --
Financing Cash Flow -607,042 -640,568 -1.5M -4.2M -554,719 --
Cash Flow From Continuing Financing Activities -607,042 -640,568 -1.5M -4.2M -554,719 --
Effect Of Exchange Rate Changes 6,979 -6,966 -671.00 31,244 -25,835 --
Changes In Cash 2.6M 3.0M -1.2M -699,311 1.0M --
Beginning Cash Position 13.9M 11.0M 12.1M 12.8M 11.8M --
End Cash Position 16.6M 13.9M 11.0M 12.1M 12.8M --
Free Cash Flow 2.5M 3.4M -806,755 2.7M 2.0M --
Income Tax Paid Supplemental Data 126,607 470,387 449,996 677,916 446,985 --
Amortization Cash Flow 135,852 144,566 144,276 164,207 46,545 --
Amortization Of Intangibles 135,852 144,566 144,276 164,207 46,545 --
Cash Dividends Paid -563,065 -562,732 -563,311 -512,891 -521,437 --
Change In Account Payable -- -950,650 757,373 -- -- 889,790
Change In Income Tax Payable -- -563,962 360,217 -- -- -263,709
Change In Prepaid Assets 103,635 41,081 -282,683 189,969 419,013 --
Change In Tax Payable -- -563,962 360,217 -- -- -263,709
Depreciation 66,353 68,075 66,907 72,113 70,298 --
Gain Loss On Investment Securities 3,539 4,261 14,450 16,462 -203.00 --
Interest Paid Cff -12,141 -12,631 -13,103 -13,971 -14,579 --
Interest Received Cfi 6,225 -853,553 1.1M -23,742 331,931 --
Long Term Debt Payments -49,354 -47,986 -47,513 -46,645 -46,038 --
Net Income From Continuing Operations 2.7M 2.0M 2.3M 1.6M 2.3M --
Net Intangibles Purchase And Sale -238,627 -25,040 -68,457 75,370 -4.6M --
Net Long Term Debt Issuance -49,354 -47,986 -47,513 -46,645 -46,038 --
Net Other Financing Charges -- -23,505 -286,834 -- -- -9,411
Net Other Investing Changes 0.00 36,571 55,425 622.00 0.00 --
Operating Gains Losses 3,539 4,261 14,450 16,462 -203.00 --
Proceeds From Stock Option Exercised 34,352 6,286 58,538 162,188 50,180 --
Provisionand Write Offof Assets -- -- -- 136,491 0.00 0.00
Purchase Of Intangibles -238,627 -25,040 -68,457 75,370 -4.6M --
NEWS
Loading news...
TRENDING
Loading...